I-01 Thomas Dumortier
Using extrapolation to support a pediatric investigational plan: an application in liver transplantation development
Wednesday 10:20-11:40 |
I-14 Aline Fuchs
Simulations to simplify gentamicin dosing regimens for neonates and young infants when referral is not possible in developing countries
Wednesday 10:20-11:40 |
I-18 Eva Germovsek
Pharmacokinetic-pharmacodynamic (PKPD) modelling of meropenem in plasma and cerebrospinal fluid (CSF) in infants with late-onset sepsis and/or bacterial meningitis
Wednesday 10:20-11:40 |
I-26 Verena Gotta
Characterizing age-dependency of cytokine levels in healthy children
Wednesday 10:20-11:40 |
I-55 Carl Johansson
Omeprazole dose recommendation in pediatric patients aged 1-11 months with erosive esophagitis
Wednesday 10:20-11:40 |
I-72 Jean Lavigne
Modeling and simulation of smear count after administration of Eurartesim® (piperaquine (PQ) tetraphosphate/dihydroartemisinin (DHA)) in infected patients with Plasmodium falciparum malaria
Wednesday 10:20-11:40 |
II-17 Charlotte Barker
Simultaneous modelling of antimicrobial pharmacokinetic data from birth to adolescence: using different penicillins to inform a common maturation function
Wednesday 15:10-16:30 |
II-21 Andrzej Bienczak
Semi-physiological pharmacokinetic/pharmacogenetic model with circadian rhythm for the characterisation of nevirapine pharmacokinetics in African children.
Wednesday 15:10-16:30 |
II-29 Agnieszka Borsuk-De Moor
Population pharmacokinetics of sufentanil after epidural and intravenous administration in children and infants
Wednesday 15:10-16:30 |
II-32 Jantine Brussee
Predictive performance of a CRP and organ failure based pharmacokinetic model for midazolam in critically ill children across external datasets in neonates, children and adults
Wednesday 15:10-16:30 |
II-35 Elisa Calvier
Allometric scaling of clearance in paediatrics: when does the magic of 0.75 fade?
Wednesday 15:10-16:30 |
II-47 Hyewon Chung
Population pharmacokinetics of F-ara-A after fludarabine administration in pediatric hematopoietic stem cell transplantation patients
Wednesday 15:10-16:30 |
II-54 Sinziana Cristea
Maturation of Glomerular Filtration throughout the paediatric age-range; a comparison of different functions
Wednesday 15:10-16:30 |
II-56 Salvatore D'Agate
Optimisation of weight-banded dosing regimens of amoxicillin in neonates and young infants with sepsis
Wednesday 15:10-16:30 |
II-59 Pieter De Cock
piperacillin-tazobactam pharmacokinetics in critically ill children: implications on adequate dosing regimens
Wednesday 15:10-16:30 |
II-64 Brenda de Winter
Pharmacokinetics of Pentobarbital in Pediatric Status Epilepticus Patients
Wednesday 15:10-16:30 |
II-76 Hélder Duarte
Amikacin in premature newborn: a new therapeutic proposal from a PopPK model
Wednesday 15:10-16:30 |
III-12 Adedeji Majekodunmi
Mechanistic modelling of naive CD4+ T cell homeostasis in HIV-infected children on anti-retroviral therapy
Thursday 10:05-11:30 |
III-20 Paolo Mazzei
Population exposure-response modeling of oral nepadutant administration in infants with colic
Thursday 10:05-11:30 |
III-28 Samer Mouksassi
Primary microcephaly: do all roads lead to Rome?
Thursday 10:05-11:30 |
III-31 Silke Gastine
Population Pharmacokinetics of Voriconazole in pediatric cancer patients - assessing new dosing strategies
Thursday 10:05-11:30 |
III-40 Sean Oosterholt
Model-based extrapolation and dosing recommendation for raxibacumab in children from birth to <18 years of age
Thursday 10:05-11:30 |
III-45 Sophie Peigne
Optimal design in the analysis of a clinical study in paediatric population
Thursday 10:05-11:30 |
III-60 Claire Pressiat
Population pharmacokinetics of cotrimoxazole In West African HIV-infected children
Thursday 10:05-11:30 |
III-71 Christelle Rodrigues
Population pharmacokinetics of oxcarbazepine and its 10-monohydroxy derivative in epileptic children
Thursday 10:05-11:30 |
IV-49 Swantje Völler
Dose Recommendations for Recombinant Asparaginase in Children: A Population Pharmacokinetic Analysis
Thursday 14:40-16:00 |
IV-60 Pawel Wiczling
A Bayesian approach for population pharmacokinetic modeling of dexmedetomidine during long-term infusion in critically ill pediatric patients.
Thursday 14:40-16:00 |
IV-62 Jayson Wilbur
Zika microcephaly cutoffs revisited: A study of Non-parametric methods in fetal growth
Thursday 14:40-16:00 |
IV-63 Julia Winkler
Population pharmacokinetics of lacosamide to support intravenous dose adaptation in children with epilepsy
Thursday 14:40-16:00 |
